Insmed Inc. buy Cantor Fitzgerald
Start price
19.09.23
/
50%
€24.40
Target price
19.09.24
€43.04
Performance (%)
172.54%
End price
20.09.24
€66.50
Summary
This prediction ended on 20.09.24 with a price of €66.50. With a performance of 172.54% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 5.983% | 5.983% | 74.648% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,04 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 13,43 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 23,57 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 8,65 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten